Acadia Healthcare (NASDAQ:ACHC) PT Lowered to $76.00

Acadia Healthcare (NASDAQ:ACHCGet Free Report) had its price objective reduced by research analysts at Barclays from $83.00 to $76.00 in a report released on Monday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s target price would indicate a potential upside of 25.52% from the stock’s current price.

ACHC has been the topic of several other research reports. Cantor Fitzgerald reiterated a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Monday, August 19th. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a research note on Friday, September 20th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $86.67.

Check Out Our Latest Stock Analysis on Acadia Healthcare

Acadia Healthcare Stock Down 4.3 %

Shares of NASDAQ ACHC traded down $2.73 during trading hours on Monday, hitting $60.55. 1,163,666 shares of the stock were exchanged, compared to its average volume of 839,182. Acadia Healthcare has a 12 month low of $53.22 and a 12 month high of $87.77. The firm has a fifty day moving average price of $74.23 and a 200-day moving average price of $71.62. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. The company has a market cap of $5.62 billion, a PE ratio of -432.50, a PEG ratio of 2.19 and a beta of 1.30.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The firm had revenue of $796.00 million during the quarter, compared to analyst estimates of $784.38 million. During the same quarter in the prior year, the business posted $0.92 EPS. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. On average, sell-side analysts expect that Acadia Healthcare will post 3.51 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors have recently bought and sold shares of the company. Franklin Resources Inc. lifted its position in shares of Acadia Healthcare by 30.2% during the fourth quarter. Franklin Resources Inc. now owns 16,632 shares of the company’s stock worth $1,293,000 after purchasing an additional 3,856 shares in the last quarter. Hsbc Holdings PLC increased its stake in Acadia Healthcare by 463.3% during the 4th quarter. Hsbc Holdings PLC now owns 53,797 shares of the company’s stock worth $4,188,000 after buying an additional 44,247 shares during the period. Treasurer of the State of North Carolina lifted its holdings in Acadia Healthcare by 1.0% during the 4th quarter. Treasurer of the State of North Carolina now owns 39,776 shares of the company’s stock worth $3,093,000 after buying an additional 390 shares in the last quarter. Capstone Investment Advisors LLC purchased a new stake in shares of Acadia Healthcare during the fourth quarter worth $204,000. Finally, The Manufacturers Life Insurance Company increased its holdings in Acadia Healthcare by 10.3% during the 4th quarter. The Manufacturers Life Insurance Company now owns 382,946 shares of the company’s stock worth $29,778,000 after purchasing an additional 35,777 shares during the period.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Further Reading

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.